- Coordinates
- PDB Format
- Method
- ELECTRON MICROSCOPY
- Oligo State
- hetero-3-3-mer
- Ligands
- 17 x NAG- NAG: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose(Non-covalent)(Post Translational Modification)
- 3 x NAG- NAG- FUC: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-[alpha-L-fucopyranose-(1-6)]2-acetamido-2-deoxy-beta-D-glucopyranose
NAG-NAG-FUC.8: 4 residues within 4Å:- Chain A: A.706, E.1072, K.1073, N.1074
No protein-ligand interaction detected (PLIP)NAG-NAG-FUC.16: 3 residues within 4Å:- Chain B: A.706, E.1072, N.1074
1 PLIP interactions:1 interactions with chain B- Hydrogen bonds: B:N.1074
NAG-NAG-FUC.24: 3 residues within 4Å:- Chain C: A.706, E.1072, N.1074
1 PLIP interactions:1 interactions with chain C- Hydrogen bonds: C:N.1074
- 6 x NAG- NAG- MAN: alpha-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose
NAG-NAG-MAN.9: 4 residues within 4Å:- Chain A: N.1098, T.1100, H.1101, F.1103
No protein-ligand interaction detected (PLIP)NAG-NAG-MAN.10: 1 residues within 4Å:- Chain A: N.1134
No protein-ligand interaction detected (PLIP)NAG-NAG-MAN.17: 4 residues within 4Å:- Chain B: N.1098, T.1100, H.1101, F.1103
No protein-ligand interaction detected (PLIP)NAG-NAG-MAN.18: 1 residues within 4Å:- Chain B: N.1134
No protein-ligand interaction detected (PLIP)NAG-NAG-MAN.25: 4 residues within 4Å:- Chain C: N.1098, T.1100, H.1101, F.1103
No protein-ligand interaction detected (PLIP)NAG-NAG-MAN.26: 1 residues within 4Å:- Chain C: N.1134
No protein-ligand interaction detected (PLIP)- 30 x NAG: 2-acetamido-2-deoxy-beta-D-glucopyranose(Post Translational Modification)(Non-covalent)(Non-functional Binders)
NAG.27: 3 residues within 4Å:- Chain A: Y.28, F.59, N.61
Ligand excluded by PLIPNAG.28: 1 residues within 4Å:- Chain A: Y.144
Ligand excluded by PLIPNAG.29: 1 residues within 4Å:- Chain A: N.234
Ligand excluded by PLIPNAG.30: 2 residues within 4Å:- Chain A: N.331, Q.580
Ligand excluded by PLIPNAG.31: 2 residues within 4Å:- Chain A: G.339, N.343
Ligand excluded by PLIPNAG.32: 2 residues within 4Å:- Chain A: T.307, N.603
Ligand excluded by PLIPNAG.33: 1 residues within 4Å:- Chain A: N.657
Ligand excluded by PLIPNAG.34: 3 residues within 4Å:- Chain A: N.709, G.1131
- Chain B: D.796
Ligand excluded by PLIPNAG.35: 1 residues within 4Å:- Chain A: N.1158
Ligand excluded by PLIPNAG.36: 0 residues within 4Å:- (No contacts)
Ligand excluded by PLIPNAG.37: 1 residues within 4Å:- Chain B: N.61
Ligand excluded by PLIPNAG.38: 4 residues within 4Å:- Chain B: N.122, A.123, T.124, N.125
Ligand excluded by PLIPNAG.39: 10 residues within 4Å:- Chain B: Q.115, V.130, E.132, N.165, C.166, T.167
- Chain D: T.28, D.98, N.100, Y.105
Ligand excluded by PLIPNAG.40: 1 residues within 4Å:- Chain B: N.282
Ligand excluded by PLIPNAG.41: 2 residues within 4Å:- Chain B: N.343, F.374
Ligand excluded by PLIPNAG.42: 1 residues within 4Å:- Chain B: N.603
Ligand excluded by PLIPNAG.43: 1 residues within 4Å:- Chain B: N.657
Ligand excluded by PLIPNAG.44: 3 residues within 4Å:- Chain B: N.709, G.1131
- Chain C: D.796
Ligand excluded by PLIPNAG.45: 1 residues within 4Å:- Chain B: N.1158
Ligand excluded by PLIPNAG.46: 2 residues within 4Å:- Chain C: Y.28, N.61
Ligand excluded by PLIPNAG.47: 2 residues within 4Å:- Chain C: F.157, Y.160
Ligand excluded by PLIPNAG.48: 3 residues within 4Å:- Chain C: K.147, N.148, N.149
Ligand excluded by PLIPNAG.49: 0 residues within 4Å:- (No contacts)
Ligand excluded by PLIPNAG.50: 2 residues within 4Å:- Chain C: T.108, T.236
Ligand excluded by PLIPNAG.51: 1 residues within 4Å:- Chain C: N.282
Ligand excluded by PLIPNAG.52: 4 residues within 4Å:- Chain C: N.343, V.367, S.373, F.374
Ligand excluded by PLIPNAG.53: 2 residues within 4Å:- Chain C: E.309, N.603
Ligand excluded by PLIPNAG.54: 1 residues within 4Å:- Chain C: N.657
Ligand excluded by PLIPNAG.55: 2 residues within 4Å:- Chain C: N.709, G.1131
Ligand excluded by PLIPNAG.56: 1 residues within 4Å:- Chain C: N.1158
Ligand excluded by PLIP- Links
- RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
- Citation
- Maeda, R. et al., A panel of nanobodies recognizing conserved hidden clefts of all SARS-CoV-2 spike variants including Omicron. Commun Biol (2022)
- Release Date
- 2022-07-20
- Peptides
- Spike glycoprotein: ABC
Neutralizing nanobody P86: DEF - SMTL:PDB
- SMTL Chain Id:
PDB Chain Id:A
AB
BC
CD
DE
EF
F
- Coordinates
- PDB Format
- Method
- ELECTRON MICROSCOPY
- Oligo State
- hetero-3-3-mer
- Ligands
- 17 x NAG- NAG: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose(Non-covalent)(Post Translational Modification)
- 3 x NAG- NAG- FUC: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-[alpha-L-fucopyranose-(1-6)]2-acetamido-2-deoxy-beta-D-glucopyranose
- 6 x NAG- NAG- MAN: alpha-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose
- 30 x NAG: 2-acetamido-2-deoxy-beta-D-glucopyranose(Post Translational Modification)(Non-covalent)(Non-functional Binders)
- Links
- RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
- Citation
- Maeda, R. et al., A panel of nanobodies recognizing conserved hidden clefts of all SARS-CoV-2 spike variants including Omicron. Commun Biol (2022)
- Release Date
- 2022-07-20
- Peptides
- Spike glycoprotein: ABC
Neutralizing nanobody P86: DEF - SMTL:PDB
- SMTL Chain Id:
PDB Chain Id:A
AB
BC
CD
DE
EF
F